| PERIOD ENDING | 2-Oct-09 | 3-Oct-08 | 30-Sep-07 | | Total Revenue | 126,552 | 160,699 | 127,805 | | Cost of Revenue | 49,981 | 47,625 | 42,334 | | | Gross Profit | 76,571 | 113,074 | 85,471 | | | Operating Expenses | | Research Development | 50,650 | 56,217 | 57,447 | | Selling General and Administrative | 41,582 | 46,984 | 43,385 | | Non Recurring | 6,896 | 211 | 4,724 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (22,557) | 9,662 | (20,085) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,811 | 544 | 522 | | Earnings Before Interest And Taxes | (19,746) | 10,206 | (19,563) | | Interest Expense | 1,803 | 2,360 | 2,240 | | Income Before Tax | (21,549) | 7,846 | (21,803) | | Income Tax Expense | 482 | 611 | 111 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,031) | 7,235 | (21,914) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (22,031) | 7,235 | (21,914) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,031) | $7,235 | ($21,914) |
|
0.01% Nasdaq 
0.22%
Income Statement
